학술논문

Analgesic nanomedicines for the treatment of chronic pain
Document Type
article
Source
BMEMat, Vol 2, Iss 1, Pp n/a-n/a (2024)
Subject
analgesics
chronic pain
local anesthetics
nanomedicine
neuroplasticity
Biotechnology
TP248.13-248.65
Materials of engineering and construction. Mechanics of materials
TA401-492
Language
English
ISSN
2751-7446
Abstract
Abstract Chronic pain is a major cause of suffering that often accompanies diseases and therapies, affecting approximately 20% of individuals at some point in their lives. However, current treatment modalities, such as anesthetic and antipyretic analgesics, have limitations in terms of efficacy and side effects. Nanomedical technology offers a promising avenue to overcome these challenges and introduce new therapeutic mechanisms. This article reviews the recent research on nanomedicine analgesics, integrating analyses of neuroplasticity changes in neurons and pathways related to the transition from acute to chronic pain. Furthermore, it explores potential future strategies using nanomaterials, aiming to provide a roadmap for new analgesic development and improved clinical pain management. By leveraging nanotechnology, these approaches hold the potential to revolutionize pain treatment by delivering targeted and effective relief while minimizing side effects.